Depth across the therapeutic areas that matter most.

Our experience spans vaccines and infectious disease, metabolic and respiratory medicine, and specialist indications, across maternal, paediatric, and adult populations.

COVID-19 Treatment

Phase 2/3 oral antivirals, four studies across high-risk, low-risk, and household-contact populations.

COVID-19 Vaccination

mRNA and multivalent vaccines across adult, maternal, and paediatric cohorts.

RSV Vaccines

Seven studies spanning maternal, adult, and paediatric populations, including participants living with HIV.

Obesity & Weight Management

GLP-1 and combination agents, including CagriSema and semaglutide programmes.

Type 2 Diabetes

Insulin and GLP-1 receptor agonists, including once-weekly insulin icodec studies.

Influenza Vaccination

Adult and paediatric programmes, including cell-based and modified-RNA vaccines.

Respiratory Medicine

Asthma (paediatric & adult) and refractory chronic cough.

Autoimmune / Rheumatology

Phase 1 basket study in select autoimmune rheumatic diseases (Sanofi).

Women's Health

CIN 2 & 3 Phase 3 open-label study (Antiva Biosciences).

Cardiovascular Disease

Incoming Phase 3 in overweight/obesity with atherosclerotic CVD (F. Hoffmann-La Roche).

Dermatology

Moderate-to-severe acne vulgaris, randomized, vehicle-controlled (AOBiome).

Severe Asthma (Biologic)

Phase 3 in adolescents and adults with severe asthma (Upstream Bio).

Populations served: maternal, paediatric, adolescent, and adult cohorts, with multilingual informed consent in English, Zulu, Sotho, and Tswana ensuring genuine participant understanding across our community.

Have a protocol in mind?

Review our full study portfolio, or email our feasibility team at feasibilities@bothokebontle.co.za to discuss your protocol.

View track record Request feasibility